Anterra Capital — 2020 Investments
4 investments dated 2020 · listed companies and verified rows first · show all
Animol is a biopharmaceutical company developing a proprietary pipeline of novel veterinary small-molecule drugs for both companion and farm animals, targeting areas from anti-parasitics to chronic diseases.
AgTechAI & Machine LearningBiotechDeep TechHealthtechBoston, US
Andrew Calabrese(Scientific Co-Founder)inAndrew Calabrese, Ph.D.(Scientific Co-Founder)Douglas E. Hutchens(CSO)inLogan Andrews(Head of Program Management)inPhilip Austin(Managing Partner, Anterra Capital; co-founder of Animol)inAndrew Plant(Executive Officer, Director)in
Co-investorsNovalis LifeSciencesDYDX Capital
Ampverse provides gaming marketing services—including influencer talent, esports, events, media and virtual worlds—connecting brands and game publishers with gaming audiences.
GamingMarketing TechMedia & Entertainment
Charlie Baillie(Chief Executive Officer)inTim Roemer(Chief Operating Officer)in
Co-investorsFirestartrGandel InvestVulpes Ventures
Enko discovers and develops novel crop protection products for farmers using a proprietary AI and machine learning discovery platform to combat pests and diseases.
AgTechAI & Machine LearningBiotechBoston, US
Jacqueline Heard(Executive Officer, Director)inTom Meade(Chief Science Officer)Philip Austin(Director)inSteffen Helmling(Director)Anthony Klemm(CEO and Board Director)
Co-investorsAlumni VenturesCastor VenturesConnecticut InnovationsDYDX CapitalEndeavor8Germin8 Ventures+5 more
Boston, US
Jurgen Horn(Executive Officer, Director)
BoardPhilip Austin(Director)in
Co-investorsF-Prime CapitalGV (Google Ventures)Casdin CapitalEight Roads VenturesNovo Holdings
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.















